Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.910
-0.070 (-1.76%)
Apr 23, 2026, 1:23 PM EDT - Market open
Cellectis Stock Forecast
Stock Price Forecast
The 3 analysts that cover Cellectis stock have a consensus rating of "Strong Buy" and an average price target of $8.33, which forecasts a 113.04% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $9.00.
Price Target: $8.33 (+113.04%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cellectis stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Reiterates $8 | Buy | Reiterates | $8 | +104.60% | Apr 14, 2026 |
| Clear Street | Clear Street | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +130.18% | Dec 23, 2025 |
| Barclays | Barclays | Buy Maintains $4 → $8 | Buy | Maintains | $4 → $8 | +104.60% | Oct 17, 2025 |
| Barclays | Barclays | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +2.30% | May 13, 2025 |
| Barclays | Barclays | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +27.88% | Nov 5, 2024 |
Financial Forecast
Revenue This Year
58.42M
from 79.59M
Decreased by -26.60%
Revenue Next Year
58.99M
from 58.42M
Increased by 0.98%
EPS This Year
-1.10
from -0.67
EPS Next Year
-1.39
from -1.10
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 66.7M | 107.2M | |||||
| Avg | 58.4M | 59.0M | |||||
| Low | 39.2M | 24.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | -16.2% | 83.5% | |||||
| Avg | -26.6% | 1.0% | |||||
| Low | -50.7% | -58.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.86 | -1.01 | |
| Avg | -1.10 | -1.39 | |
| Low | -1.59 | -1.79 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.